Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2

Status

Recruiting 6Active not recruiting 6Unknown 2Terminated 2Withdrawn 1Completed 1

Sponsor Class

OTHER 6INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 2Tumor-Agnostic 1Other solid neoplasm 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Neoplasms 2Head and Neck Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Melanoma 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × OTHER × Tiragolumab × Clear all
NCT05394337 2026-05-05

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
10 enrolled
Tumor-Agnostic

Neoplasms

NCT04486352 2026-04-01

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting
148 enrolled
Gynecologic

Endometrial Neoplasms

NCT05483400 2025-03-30

TIRACAN

University Medical Center Groningen

Phase 2 Recruiting
97 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

NCT03708224 2025-01-28

Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

University of California, San Francisco

Phase 2 Recruiting
55 enrolled
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT06003621 2024-11-15

MoST-TAP

Omico

Phase 2 Recruiting
96 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT06342037 2024-09-19

TONIC-3

The Netherlands Cancer Institute

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡